Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-24-023207

Options or other derivatives

  • Director acquired 1,764 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fink Jeffrey Arvin Director 2024-06-05 Grant or award · Common Stock (Right to Buy) +1,764 $7.05 $12,436 10,938 D
Loading xslF345X05/ownership.xml…